Thalys Medical Technology Group Corporation (SHSE:603716) announces a share repurchase program. Under the program, the company will repurchase up to CNY 20 million worth of its shares. The shares will be repurchased at no more than CNY 12.16 per share.

The purpose of the program is to to safeguard the company's value and shareholders' rights and interests. The program will be funded from company's own funds. The plan will be valid till May 5, 2024.